Dermata Therapeutics, Inc. — Form D

Dermata Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-28. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Gerald ProehlDirectorSAN DIEGO, CA
Gerald ProehlExecutive OfficerSAN DIEGO, CA
Brittany J BradrickDirectorSan Diego, CA
Christopher J NardoExecutive OfficerSan Diego, CA
Maria J Bedoya Toro MuneraExecutive OfficerSan Diego, CA
Steven J MentoDirectorSan Diego, CA
Mary J FisherDirectorSan Diego, CA
Kathleen J ScottDirectorSan Diego, CA
Kyri K Van HooseExecutive OfficerSan Diego, CA
Wendell J WierengaDirectorSan Diego, CA
Andrew J SandlerDirectorSan Diego, CA
David J HaleDirectorSan Diego, CA
Gerald T ProehlDirectorLa Jolla, CA
Gerald T ProehlExecutive OfficerLa Jolla, CA
Maria J. Bedoya Toro MuneraExecutive OfficerSAN DIEGO, CA
Mary J. FisherDirectorSAN DIEGO, CA
Kathleen J. ScottDirectorSAN DIEGO, CA
Steven J. MentoDirectorSAN DIEGO, CA
Wendell J. WierengaDirectorSAN DIEGO, CA
Andrew J. SandlerDirectorSAN DIEGO, CA
Kyri K. Van HooseExecutive OfficerSAN DIEGO, CA
David J. HaleDirectorSAN DIEGO, CA
Christopher J. NardoExecutive OfficerSAN DIEGO, CA
Brittany J. BradrickDirectorSAN DIEGO, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2026-01-07D$4.1M$4.1M
2025-02-04D/A$2.5M$2.5M
2024-09-27D$3.5M$3.5M
2023-06-12D——

More